- Home
- ITRG vs CTXR Comparison
ITRG vs CTXR Comparison
Compare ITRG & CTXR Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- ITRG
- CTXR
- Stock Information
- Founded
- ITRG 1997
- CTXR 2007
- Country
- ITRG Canada
- CTXR United States
- Employees
- ITRG N/A
- CTXR N/A
- Industry
- ITRG Precious Metals
- CTXR Biotechnology: Pharmaceutical Preparations
- Sector
- ITRG Basic Materials
- CTXR Health Care
- Exchange
- ITRG Nasdaq
- CTXR Nasdaq
- Market Cap
- ITRG 92.0M
- CTXR 84.9M
- IPO Year
- ITRG N/A
- CTXR N/A
- Fundamental
- Price
- ITRG $0.91
- CTXR $0.37
- Analyst Decision
- ITRG Strong Buy
- CTXR Strong Buy
- Analyst Count
- ITRG 1
- CTXR 2
- Target Price
- ITRG $3.75
- CTXR $5.00
- AVG Volume (30 Days)
- ITRG 369.7K
- CTXR 1.4M
- Earning Date
- ITRG 11-13-2024
- CTXR 12-27-2024
- Dividend Yield
- ITRG N/A
- CTXR N/A
- EPS Growth
- ITRG N/A
- CTXR N/A
- EPS
- ITRG N/A
- CTXR N/A
- Revenue
- ITRG N/A
- CTXR N/A
- Revenue This Year
- ITRG N/A
- CTXR N/A
- Revenue Next Year
- ITRG $360.52
- CTXR N/A
- P/E Ratio
- ITRG N/A
- CTXR N/A
- Revenue Growth
- ITRG N/A
- CTXR N/A
- 52 Week Low
- ITRG $0.64
- CTXR $0.25
- 52 Week High
- ITRG $1.28
- CTXR $1.07
- Technical
- Relative Strength Index (RSI)
- ITRG 32.16
- CTXR 40.18
- Support Level
- ITRG $0.91
- CTXR $0.31
- Resistance Level
- ITRG $1.10
- CTXR $0.51
- Average True Range (ATR)
- ITRG 0.06
- CTXR 0.05
- MACD
- ITRG -0.03
- CTXR 0.01
- Stochastic Oscillator
- ITRG 3.00
- CTXR 11.62
About ITRG Integra Resources Corp.
Integra Resources Corp is a precious metals exploration and development company in the Great Basin of the Western USA. Integra is currently focused on advancing its two flagship oxide heap leach projects: the past-producing DeLamar Project located in southwestern Idaho and the Nevada North Project, comprised of the Wildcat and Mountain View deposits, located in northwestern Nevada. The company also holds a portfolio of highly prospective early-stage exploration projects in Idaho, Nevada, and Arizona.
About CTXR Citius Pharmaceuticals Inc.
Citius Pharmaceuticals Inc is a biopharmaceutical company with a focus on anti-infectives in adjunct cancer care, prescription products, and stem cell therapy. It is currently advancing four proprietary product candidates: LYMPHIR for the treatment of patients with persistent or recurrent cutaneous T-cell lymphoma . Mino-Lok, which is an antibiotic lock solution used to treat patients with catheter-related bloodstream infections; Mino-Wrap, a liquifying gel-based wrap for reduction of tissue expander infections following breast reconstructive surgeries; Halo-Lido, a topical formulation that is intended to provide anti-inflammatory and anesthetic relief to persons suffering from hemorrhoids; NoveCite, a mesenchymal stem cell therapy for the treatment of acute respiratory distress syndrome.